Delivery Order SPE2DB25D2203-SPE2DB25FPSFP
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $7.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 6, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used for osteoarthritis treatment. This firm fixed price delivery order, valued at $5,019.40, represents a competitive award with no set-aside designation and is scheduled for completion by August 7, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,942.56 delivery order on July 29, 2025, for Synvisc-One Syringe 6ML, a hyaluronic acid-based intra-articular injection used for osteoarthritis pain management. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition...
- The Defense Logistics Agency awarded a $2,370.86 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used for knee osteoarthritis treatment. This non-set-aside, competitively awarded contract is scheduled for completion by July 21, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $7,898.36 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for Synvisc-One syringes (6mL), with completion targeted for September 9, 2025. This firm fixed-price, non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $2,560.80 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for SYNVISC-One Syringe 6ML, a hyaluronic acid-based injection used for osteoarthritis treatment. This firm fixed-price delivery order, with completion expected by September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $10,419.84 for Synvisc-One Syringe 6ML, a hyaluronic acid-based joint injection used to treat osteoarthritis pain. The contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, is a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Synvisc-One syringes (6mL) with a ceiling value of $3,885.12 under a firm fixed-price contract type. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 22, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,605.68 to AmerisourceBergen Drug Corp for SYNVISC-One Syringe 6ml, a hyaluronic acid-based joint injection used to treat osteoarthritis symptoms. The contract, issued on September 9, 2025, with a completion date of September 10, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a $25.2K delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid-based joint injection used for osteoarthritis treatment. This firm fixed-price, non-set-aside contract is scheduled for completion by September 18, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,479.42 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a joint care injection medication. This firm fixed-price contract, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...